These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7570339)

  • 1. Binding and internalization of neurotensin in hybrid cells derived from septal cholinergic neurons.
    Faure MP; Labbé-Jullié C; Cashman N; Kitabgi P; Beaudet A
    Synapse; 1995 Jun; 20(2):106-16. PubMed ID: 7570339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a biologically active fluorescent probe for labeling neurotensin receptors.
    Faure MP; Gaudreau P; Shaw I; Cashman NR; Beaudet A
    J Histochem Cytochem; 1994 Jun; 42(6):755-63. PubMed ID: 8189037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon.
    Azriel Y; Burcher E
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1074-81. PubMed ID: 11356931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
    Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
    Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of 125I-neurotensin binding sites in human forebrain: comparison with the localization of acetylcholinesterase.
    Szigethy E; Quirion R; Beaudet A
    J Comp Neurol; 1990 Jul; 297(4):487-98. PubMed ID: 2166757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
    Donato di Paola E; Cusack B; Yamada M; Richelson E
    J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and internalization of neurotensin in hybrid cells derived from septal cholinergic neurons.
    Faure MP; Shaw I; Gaudreau P; Cashman N; Beaudet A
    Ann N Y Acad Sci; 1992; 668():345-7. PubMed ID: 1334390
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Quirion R; Welner S; Gauthier S; Bédard P
    Synapse; 1987; 1(6):559-66. PubMed ID: 2843996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin.
    Scarcériaux V; Souazé F; Bachelet CM; Forgez P; Bourdel E; Martinez J; Rostène W; Pélaprat D
    J Neuroendocrinol; 1996 Aug; 8(8):587-93. PubMed ID: 8866245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.
    Carraway RE; Gui X; Cochrane DE
    J Pharmacol Exp Ther; 2003 Nov; 307(2):640-50. PubMed ID: 14570823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism.
    Botto JM; Chabry J; Sarret P; Vincent JP; Mazella J
    Biochem Biophys Res Commun; 1998 Feb; 243(2):585-90. PubMed ID: 9480852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist induced conformation alteration of neurotensin receptor and the mechanism behind Na+ inhibition of 125I-NT binding.
    Mitra SP; Carraway RE; Blute R; Luber-Narod J
    J Recept Signal Transduct Res; 1999 Nov; 19(6):995-1021. PubMed ID: 10533985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural localization of [125I]neurotensin binding sites to cholinergic neurons of the rat nucleus basalis magnocellularis.
    Szigethy E; Leonard K; Beaudet A
    Neuroscience; 1990; 36(2):377-91. PubMed ID: 1699163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
    Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
    Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin binding sites in the forebrain and midbrain of the pigeon.
    Brauth SE; Kitt CA; Reiner A; Quirion R
    J Comp Neurol; 1986 Nov; 253(3):358-73. PubMed ID: 3025271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
    García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA
    Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.
    Nouel D; Faure MP; St Pierre JA; Alonso R; Quirion R; Beaudet A
    J Neurosci; 1997 Mar; 17(5):1795-803. PubMed ID: 9030638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of excitotoxic lesions of the medial prefrontal cortex on density of high affinity [125I-Tyr3]neurotensin binding sites within the ventral midbrain and striatum.
    Radja F; Bauco P; Rompré PP
    Eur J Pharmacol; 2006 Jun; 539(3):158-63. PubMed ID: 16714012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
    Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.